Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte 6% versus Ionolyte in elective abdominal surgery
2016-002162-30Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypovolemia comparing Volulyte 6% with Ionolyte (2 arms). Primary endpoint: Change in eGFR based on postoperative cystatin-C. Started Aug 2016; status: completed.
02
Drugs
hetastarchIonolyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on 2016-002162-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002162-30.